Functional recovery after spinal cord injury (SCI) may result in part from axon outgrowth and related plasticity through coordinated changes at the molecular level. We employed microarray analysis to identify a subset of genes the expression patterns of which were temporally coregulated and correlated to functional recovery after SCI. Steady-state mRNA levels of this synchronously regulated gene cluster were depressed in both ventral and dorsal horn neurons within 24 h after injury, followed by strong re-induction during the following 2 wk, which paralleled functional recovery. The identified cluster includes neuritin, attractin, microtubuleassociated protein 1a, and myelin oligodendrocyte protein genes. Transcriptional and protein regulation of this novel gene cluster was also evaluated in spinal cord tissue and in single neurons and was shown to play a role in axonal plasticity. Finally, in vitro transfection experiments in primary dorsal root ganglion cells showed that cluster members act synergistically to drive neurite outgrowth.
12), extracellular matrix protein members, and myelin-associated glycoproteins (13) (14) (15) (16) (17) (18) . Membrane-bound proteins and growth cone proteins such as GAP-43, CAP-23, and cell adhesion molecule (CAM) family members, which are involved in cell contact and cell adhesion, appear to be particularly important players in neurite outgrowth and plasticity after neuronal injury (19) (20) (21) (22) (23) (24) . Programmed cell death as well as axonal plasticity/outgrowth are processes essential to normal development. The altered regulation of several such classes of factors that are active in development may be recapitulated after injury and associated with either secondary injury or recovery (25) (26) (27) (28) (29) . We have recently shown that degenerative processes related to DNA damage and neuronal apoptotic cell death occur within the first days after SCI and relate in part to activation of cell cycle genes (30) . Our previous study examined expression profiles only up to 7 days after trauma using a relatively limited array of ~8000 gene and EST sequences (30) . In the present study, we have extended our temporal analysis to 28 days after injury and have increased probe sets studied to all available genes and ESTs in the rat (24,000 probe sets).
Our goal was to identify potential genes (and proteins) involved in axonal plasticity or regeneration and to functionally characterize their interactions. Coordinated gene changes are important for such complex biological processes, and their analysis may provide insight into the hierarchical organization of pathways that can suggest new approaches to therapy. Consequently, we have focused on coordinated changes in genes functionally related to neuritogenesis, axonal plasticity, and myelination and studied their temporal expression patterns after injury.
We have identified the early repression followed by delayed re-activation of gene expression after SCI for a specific cluster of temporally coregulated transcripts that include neuritin, attractin, microtubule-associated protein 1A (Mtap1a; MAP1A in human), and myelin oligodendrocyte protein (MOG). Regulation of this group of genes was also investigated in single neurons and verified at the mRNA and protein levels. In addition, we compared colabeling with the regeneration marker GAP-43 and examined effects of in vitro overexpression of the cluster on neurite outgrowth in dorsal root ganglia (DRG) neurons.
MATERIALS AND METHODS

Experimental spinal cord injury and expression profiling
Mild spinal cord injury (SCI) was performed in rats, as described previously (30) . Briefly, male Sprague-Dawley rats (275-325 g) were anesthetized with pentobarbital sodium (65 mg/kg ip). Injury was induced using a weight drop method (10 g dropped from 17.5 mm). Animals with this injury level show mild motor impairment on the Basso, Beattie, Bresnahan scale, averaging 12 ± 1, 14 ± 1, and 17 ± 1, respectively, at 7, 14, and 28 days after injury. Animals were fully anesthetized with penthobarbital sodium (67 mg/kg) during the operative procedures and experiments complied fully with the principles set forth in the "Guide for the Care and Use of A 1 cm section of the spinal cord, including 0.5 cm above and below the injury site centered at T-9, was dissected and immediately fresh frozen in liquid nitrogen. Spinal cords were collected from four injured and two sham-operated rats (receiving only laminectomy) for each time point (4 h, 24 h, 7, 14, and 28 days; 3 animals) and two naïve controls (rats that did not undergo any surgical procedure) for a total of 31 animals. Seven micrograms of total RNA were used for cDNA and biotinylated complementary RNA (cRNA) synthesis. Expression profiling analysis was performed using the Affymetrix rat U34A, B, and C arrays. Each genechip was used for a single hybridization with RNA isolated from one spinal cord sample from a single animal. Total of samples was 31.
Expression profiling was performed as described previously (30) . Briefly, RNA was extracted from each cord sample individually using TRIzol reagent (Invitrogen) and processed for chip hybridization using the protocol of the manufacturer (Affymetrix).
Microarray (genechip) quality control and normalizations
We employed stringent quality control methods as previously published (30) and detailed on our web site: (http://pepr.cnmcresearch.org/). Expression profiles fulfilled the following quality control measures: cRNA fold changes between 5 to 10, scaling factor from 0.3-1.5, percentage of "present" (P) calls from 40-55%, average signal intensity levels between 900-1100, and housekeeping genes and internal probe set controls showed >80% present calls, consistent values and 5′/3′ ratios >0.8. To detect saturated probe sets, scans were done both after initial streptavidin/phycoerythrin binding (scan 1) and after biotin/streptavidin/phycoerythrin amplification signal (scan 2). Comparison of hybridization intensity defined by a scatter plot between scan 1 and 2 showed <3% saturated probe sets. Saturated probes were flagged, and values for scan 1 were used to detect differential gene expression.
We used two normalization processes: one for chip-chip comparisons (scaling factors), and one for temporal analysis (normalization to the average of the naïve signal intensities for each gene). The scaling factors determinations were done using default Affymetrix algorithms (MAS 5) with a target intensity of chip sector fluorescence to 800. Both pre-amplification (s1) and postamplification with streptavidin/phycoerythrin (s2) scans were done, and the scans were compared by scatter plots and correlation coefficients (30) . Those probe sets showing evidence of saturation of the PMT in s2 were flagged.
Data scrubbing and statistical analysis
We have recently shown that use of Affymetrix MAS 5.0 signal intensity values, together with a "present call" noise filter, achieves an excellent signal/noise balance relative to other probe set analysis methods (dchip, RMA) (31) . Data analyses were limited to probe sets that showed 1 or more "present" (P "calls") in the 79 genechip profiles in our complete dataset (31) . Experiment normalization was performed by normalizing gene chips from injured and sham controls to the mean of the two chips from naïve animals considered as the baseline gene expression level. Normalized data were then compared for differential gene expression analysis across time points between sham and injured groups. Genes that showed a Welch ANOVA t test P value <0.05 between sham and injured groups for at least one time point were retained for further analysis. Initial data analysis also included a fold change filter of >1.5 (50% difference) increase or decrease relative to sham-operated animals (Affymetrix MAS 5.0). Although a P value of <0.05 alone would give many false positives, the combination of present call filters, fold change 
Quantitative multiple fluorescent-RT-PCR of spinal cord tissue
Quantitative multiple fluorescent (QMT)-RT-PCR was performed as described previously (30) . Briefly, three pairs of primers (2 control genes and 1 experimental gene) were labeled with the same infrared dye and mixed in the same PCR reaction for a total of 15 cycles. The quantity of the expression level for each experimental gene vs. each control gene was calculated based on the ratio between the intensity value of the experimental gene vs. control 1 and vs. control 2 for each sample for a total of eight comparisons for the injured group and four for the sham. An ANOVA t test was performed to generate P values between injured and sham for each experimental gene.
In situ hybridization
The tissue sections were removed from -80°C freezer, fixed in 4% paraformaldehyde for 1 h, and rinsed twice in 2× SSC (300 mM sodium chloride, 30 mM sodium citrate, pH 7.2). The sections were then acetylated in 0.1 M triethanolamine, pH 8.0, with 0.25% acetic anhydride (10 min) and dehydrated through graded alcohol. 35 S-labeled cRNA probes were diluted to 2 × 10 6 /70 µl in 50% hybridization buffer (50% formamide, 10% dextran sulfate, 3×SSC, 50 mM sodium phosphate buffer, pH 7.4, 1× Denhart's solution, 0.1 mg/ml yeast tRNA and 30 mM DTT). Diluted probes (70 µl) were placed on each slide, and the sections were coverslipped. Hybridization was performed in an incubator at 55°C for 16 h. After incubation, coverslips were lifted with 2× SSC, rinsed three times in 2× SSC, then incubated in RNase A (200 µg/ml) for 1 h at 37°C, followed by a wash sequence: 2× SSC, 1× SSC, 0.5× SSC and 0.1× SSC (5 min each at room temperature). Finally, the sections were washed in 0.1× SSC at 70°C for 1 h and then rinsed in distilled water and dehydrated in a graded series of alcohols. Sections were exposed to X-ray film (Kodak BioMax MR) and then dipped in Kodak NTB2 autoradiography emulsion. The specificity of in situ hybridization signals was assured by hybridizing tissue sections with three antisense probes generated to different regions of the attractin, neuritin, and Mtap1a genes (sequences corresponding to GeneBank accession numbers AA859645, U88958, M83196), incubating sections with three sense strand probes or pretreating the tissue with Rnase A (200 µg/ml at 37°C for 60 min) before hybridization with antisense probes. The autoradiographic images from the films or emulsion were captured and analyzed with a MCID/M5 image analysis system (Imaging Research, ON, Canada). Anatomical localization was verified according to the rat spinal cord atlas.
Laser microdissection QMF-RT-PCR
Twelve micromolar frozen sections were cut from both sham and injured animals 0.5 cm above and 0.5 below injury or laminectomy site and collected on polarized RNase free slides and immediately processed for laser microdissection microscopy (LMD). Tissue sections were first subjected to dehydration steps and then stained with cresyl violet or immunocytochemically for NeuN antibody. For histochemistry, sections were fixed in ethanol 70% for 15 s, DEPC water for 30 s, stained with cresyl violet for 4 min, and dehydrated in 95%, and 100% ethanol for 15 s each, and then air dried for 10-15 min before cell collection by LMD. For immunohistochemistry, sections were fixed in paraformaldeyde 4% for 3 min, dehydrated as above, and then incubated for 5 min with primary antibody (rabbit anti-rat NeuN) (Chemicon, Tamecula) in PBS and 1% Triton X. They were then washed for 5 min and incubated with secondary fluorescein labeled antibody for 5 min. After an additional wash in PBS for 3 min, sections were dehydrated with 95% ethanol for 15 s, 100% ethanol for 15 s. Slides were then air dried for 10-15 min before LMD.
Individual neurons from ventral and dorsal horns were collected (100 cells per each sample) by LMD (Leica) and transferred to a tube with lysis buffer. RNA extraction included DNase I treatment (Stratagene RNA extraction kit). Total RNA from each sample was converted into double stranded cDNA by using SuperScript choice system (Gibco) with an oligo-dT primer containing T7 RNA polymerase promoter (Genset). The double-stranded cDNA was purified by phenol/chloroform extraction and then used for in vitro transcription using MegaScript Ambion IVT kit. cRNA was purified (Qiagen columns) and measured. The same amount of cRNA was then used to perform single-strand cDNA synthesis. cDNA was then purified (Qiagen PCR-DNA purification kit) and boiled for 3 min. This was used for QMF-RT-PCR (see QMF-RT-PCR section in Materials and Methods).
Immunoblotting
Protein extracts were recovered from the lower organic phase of TRIzol after supernatant isolation for RNA extraction (Gibco). Proteins were then quantified using Bradford method and 50 µg of proteins solubilized in Laemmli sample buffer supplemented with protease inhibitors (10 mg of aprotinin per ml, 1 mg of leupeptin per ml, 1 mM phenylmethlsulfonyl fluoride). Immunoblotting was done using standard methods with 4-12% SDS-PAGE gels.
The following primary antibodies were used: goat anti-neuritin, goat anti-MG/attractin, goat anti-MOG (Santa Cruz, La Jolla, CA, diluted 1:200); rabbit anti-neuritin (RD, diluted 1:1000), rabbit anti-attractin, rabbit anti-GAP-43, mouse anti-GAP-43, mouse anti-MOG (Chemicon, Temecula, CA, diluted 1:1000).
Immunocomplexes were visualized with ECL chemiluminescence (Amersham).
Immunocytochemistry
Frozen sections (12 µm) sections from three injured and two sham spinal cords were incubated under the same coverslip and processed for immunocytochemistry. Sections were processed between 0.4 and 0.5 cm below or above the lesion epicenter (injured) or the site of laminectomy (sham). Sections were first dried at room temperature, fixed in 4% paraformaldehyde, rinsed in PBS, and incubated with 10% normal serum and 0.2% Triton X in PBS (goat or rabbit depending on the secondary antibodies used) for 60 min to mask nonspecific adsorption sites. Sections were then incubated overnight at 4°C with one or more of the following primary antibodies: goat antineuritin, goat anti-attractin, goat anti-MOG (diluted 1:100); rabbit anti-neuritin (RD, diluted 1:500), rabbit anti-attractin, rabbit anti-GAP-43, mouse anti-GAP-43, mouse anti-MOG (diluted 1:500).
Omission of the primary antibodies or their replacement by preimmune sera was used for control experiments. After several rinses in PBS, the sections were incubated with the appropriate rhodamine, Texas red, FITC, or AMCA-coupled secondary antibodies (goat anti-mouse or goat anti-rabbit) for 1 h at room temperature and washed in PBS before the slides were mounted with aqueous medium. Double labeling was also performed combining mouse monoclonal anti-rat neuN (Chemicon, diluted 1:100) and rabbit polyclonal anti-rat GFAP (Chemicon, diluted 1:200) with each of the above antibodies.
Photomicrographs were taken using 3-D de-convolution microscope (Zeiss) and AxioVision image analysis software.
Real-time RT-PCR in DRG cells
We studied neuritin, attractin, and Mtap1a temporal gene expression in DRG cells by real-time PCR. We cultured E14 DRG cells obtained from Sprague-Dawley rats in differentiation medium for 1 week and measured mRNA levels. This measurement was set as our baseline (100% expression) and was followed by a temporal profiling at 2, 3, and 5 wk in culture (see Results). Fluorophore-labeled LUX primers (forward) and their unlabeled counterparts (reverse) were provided by Invitrogen. LUX primers were designed within Affymetrix probe sets sequences for each gene, and all primers were designed using the software called LUX Designer (Invitrogen, www.invitrogen.com/lux). We performed multiplex PCR combining in the same PCR mix each experimental gene with the housekeeping gene GAPDH. For each sample, 20 PCR contained 2 µl cDNA (first diluted 1:10 after reverse transcription), 200 nM of each gene-specific primer (two pairs for multiplex PCR) and 1× platinum quantitative PCR SuperMix-UDG (Invitrogen), and 1× ROX reference dye (500 nM in SuperMix). PCR conditions were standard (Invitrogen, www.invitrogen.com/lux), and reactions were conducted in a 96-well spectrofluorometric thermal cycler (ABI PRISM 7700 Sequence detector system, Applied Biosystems). Fluorescence was monitored during every PCR cycle at the annealing or extension step and during the post-PCR temperature ramp. Fold changes were measured according to the instructions of the manufacturer (Invitrogen), and ANOVA t test was used for statistical analysis.
Clones and transfection experiments
Neuritin full-length cDNA expression construct in pCMV SPORT6 was purchased from Invitrogen Inc. (catalog no. 5367281). Complete LC2 cDNA representing the cleaved LC2 from human MAP1A mRNA (92% identity at protein level with rat Mtap1a LC2) was cloned into pSec Tag2-A (Invitrogen) with a C-terminal myc-His tag; complete membrane attractin was cloned into pcDNA 3.1 (Invitrogen) with a C-terminal myc-His tag as described previously (32) .
Embryonic day 14 DRG neurons were removed and dissociated as described previously (33) . Briefly, E14 embryos were collected and placed in cold L-15 medium, the head and tail removed, and skin overlaying the spinal cord cut. The spinal cord with DRG attached was removed using fine curved forceps, the ganglia isolated, and excess meninges trimmed. Ganglia were suspended in L-15 medium containing 0.25% trypsin and incubated at 37 degrees for 15 min, and fetal bovine serum was added to 10% final concentration, washed, and then dissociated by titration with a fire polished pipette. DRG neurons were cultured in Neurobasal medium (Gibco) supplemented with B-27, 2 mM L-glutamine, 50 units penicillin-streptomycin, and 50
Page 6 of 29 (page number not for citation purposes) ug/ml BDNF. Some cultures were treated with 1 × 10 -5 flurodeoxyuridine-1 × 10 -5 uridine 24 h after plating for 2 days to reduce nonneuronal cells. Cells were transfected after 7 days in culture. For transfection, cells were seeded onto glass coverslips (circular, 13 mm in diameter) coated with poly-D-lysine and laminin (Biomedical Technologies Inc.) in 24-well plates at a density of 2.5 × 104 cells/well and cultured for 72 h. Transfection experiments were performed using the NeuroPORTER Transfection Kit (Sigma). Neuritin, membrane attractin, and MAP1A-LC2 were transfected alone and in combination to evaluate synergism upon neurite outgrowth. Recombinant plasmid DNA encoding GFP was included in transfections to monitor transfected cells. Furthermore, anti-MYC-tag antibodies (Invitrogen Inc.) were also employed to detect expression of our plasmid DNAs after transfection. Cells were stained with both β III tubulin and GAP-43 (Chemicon) antibodies to identify both cell body and processes of neurons undergoing plasticity. Neurite outgrowth was evaluated measuring the neurite length of the longest neurite per cell counting only processes positive for GFP, β III tubulin, and GAP-43. Measurements were conducted in three different experiments by two different operators. Cells were viewed using a CCD camera and analyzed with image analysis software AxioVision 3.1 (Zeiss).
RESULTS
Temporal regulation of neuritogenesis, axonal plasticity, and myelinogenesis clusters after SCI
We performed expression profiling for ~24,000 probe sets using Affymetrix high density oligonucleotides arrays (U34 A, B, and C chips) in the time series 4 h, 24 h, 7 days, 14 days, and 28 days after SCI. We applied a "present call" noise filter (1 in 79 arrays), fold change thresholds (>1.5), and P value <0.05 as our initial dataset for preliminary analysis and pathway identification. This analysis led to further consideration of ~6000 transcripts of which 5% would be expected to be false positives. Files from all 79 arrays are available from our web site, including .dat, .cel, and .txt files (http://pepr.cnmcresearch.org/browse.do).
This web site includes an on-line time series query tool of this dataset (http://pepr.cnmcresearch.org/jsp/searchForm.jsp). The spreadsheets showing all genes profiling preliminary analysis criteria are also available on the web site.
In our initial data analysis, we searched for differentially expressed transcripts related to neuronal plasticity and neurite outgrowth that play a role during development with the goal to nucleate a coordinated cluster of genes may have such actions after SCI. Neuritin, a protein known to be important in neuritogenesis and plasticity, showed significantly reduced expression at 24 h, with subsequent expression recovery between 7 and 14 days (Fig. 1, red box) . This temporal expression pattern showed repression of neuritin at a time point where we previously observed occurrence of neuronal cell death, followed by de-repression at time points when functional recovery is observed. This neuritin temporal profile was used to identify potential neuritogenesis related transcripts using a correlation coefficient of 0.98. This gene cluster included the following transcripts: neuritin as the reference transcript, ankyrin 3, ankyrin 190 K d isoform, myocilin, attractin, n-chimaerin, tau, brevican, dynamin-1, neuronatin, Mtap1a, secretogranin III, and MOG. The 14 day time point was used to further focus the target cluster, since by this time point there was a distinct functional improvement in motor scores likely associated with a microenvironment favoring regeneration. Consequently, only genes of the neuritin cluster that were further increased at this time point in injured compared with sham animals were considered for additional analyses. These included Mtap1a, attractin, and MOG (Fig. 1 ). All were significantly down-regulated as compared with the corresponding sham profiles at 24 h after injury (Fig. 1) .
Within the identified cluster, no significant changes were observed at 4 h, the recovery in mRNA expression started to take place at 7 days, while the transcript profile had leveled off or begun to decline by 28 days (Fig. 1) . Expression of the transcripts for neuritin, attractin, Mtap1a, and MOG was validated through QMF-RT PCR. For each gene, we processed the same total RNA used for microarray profiling and synthesized single-stranded cDNA from each injured (4 samples) and sham (2 samples)-operated animal. Each experimental gene was compared with the ubiquitously expressed rat liver s1-1 and 2,4 dienoyl-CoA reductase precursor as two control genes chosen for their flat gene expression profile (similar absolute intensity values) across time points in both injured and sham rats. The QMF-RT-PCR technique revealed both similar fold changes and significant t test P values in the expression level of all the transcripts studied at the time point 24 h relative to sham-operated controls ( Fig. 2A ; Table 1 ).
In contrast to the neuritin gene cluster, proteolgycan-related genes (neurocan and versican), involved in scar formation and inhibition of axonal regeneration (16, 18) , showed increased expression at 24 h in the injured cords relative to shams. Similarly, the transcript Nogo protein, one of the major myelin inhibitors (14, 17) , showed increased mRNA levels at 24 h after injury, quickly returning to sham levels at later time points. Other myelin inhibitory genes including myelin associated glycoprotein (MAG) and myelin oligodendrocyte basic protein (MOBP) showed similar expression patterns in sham and injured cords, as they did not show significant changes over time.
The up-regulation of this subset of regeneration inhibitory factors at 24 h after injury temporally corresponds to down-regulation of neuritin, Mtap1a, attractin, and MOG. The reestablishment of normal levels of the same inhibitory factors at later time points (7-28 days) may suggest the presence of a favorable environment for spontaneous reparative processes, triggered by the transcriptional activation of neuritogenesis-related genes.
Transcripts related to proliferation and neurogenesis, including markers of undifferentiated precursors such as vimentin, did not show significantly altered expression across time points between sham and injured. Similarly, transcripts corresponding to neuronal specific proteins involved in the mature neuronal cytoskeleton (neurofilament proteins), even though they were slightly reduced at 24 h, did not change significantly in the same timeframe (24 h-14 days).
Neuritin, Mtap1a, and attractin transcriptional regulation occurring in neurons is not due to cell loss
To localize and quantify the differential expression of specific transcripts at the cellular level in a cellular environment as heterogeneous as the spinal cord, we performed both in situ hybridization to spinal cord sections and QMF-RT-PCR from individual neurons. Hybridization in situ showed the specific neuronal localization of neuritin and Mtap1a as well as the preferential neuronal localization for attractin (also present in glial cells). Chronological examination by in situ hybridization confirmed the repression of these transcripts at 24 h (Fig.  3A , B, E, and F) and recovery at 14 days in injured cords (Fig. 3C and D) . Single cell QMF-RT-PCR on individual neurons from ventral and dorsal horns collected by LMD was performed to measure the level of these transcripts at 24 h and 14 days after injury. Neuritin, Mtap1a, and attractin mRNAs were all expressed in neurons and showed significant down-regulation at 24 h, with recovery at 14 days in the injured cords (Fig. 2B) . Furthermore, we found that the original profiles showing the down-regulation of neuritogenesis transcripts was not due to cellular loss, as control gene expression did not change between sham and injured cords (Fig. 2B) .
Neuritogenesis/myelinogenesis-related protein expression correlates with mRNA levels
Immunoblotting showed significantly decreased protein levels for neuritin, attractin, and MOG at 24 h after injury followed by a significant recovery of expression (several fold change for each protein) at 14 days (Fig. 4) . This trend in protein expression corresponded well with transcript levels by both expression profiling and Q-RT-PCR. GAP-43 was also coregulated with these proteins, as shown by the increment in expression level between 24 h and 14 days in the injured cords (Fig. 4) .
Neuritin, attractin, Mtap 1a, and MOG are repressed at 24 h and reexpressed in neurons and axons positive for the pro-regeneration marker GAP-43 at 14 days
Neuritin, Mtap1a, and attractin were studied by immunocytochemistry at the time points 24 h and 14 days after injury in both sham and injured samples (in triplicate).
Preferential expression in dorsal horns was observed (Fig. 5) . Faint positive staining was visible in the spinal cords 24 h after injury for all proteins studied (Fig. 5B, F , and J) compared with shams ( Fig. 5A, E, and I) . By 14 days after injury, protein expression in injured spinal cords was comparable to shams (Fig. 5C, D 
, G, H, K, and L).
Also, injured spinal cords at the same time point (14 days) showed a near normal MOG immunoreactivity, which was comparable to shams ( Fig. 5O and P) , whereas 24 h after injury there was an evident reduction of MOG positive fibers in large areas of the white matter ( Fig. 5M  and N) .
Immunostaining revealed a specific, primarily membrane-associated signal, in both dorsal and ventral horns neurons, and in axons in both gray and white matter for neuritin and attractin (Fig.  6A-F ). Mtap1a showed a membrane and a slightly more diffuse staining also in cytoplasm (Fig.  6G-I) . Neuritin, attractin, and Mtap1a showed colocalization with each another (Fig. 7) , and with the regeneration and plasticity associated protein GAP-43 ( Figs. 8 and 9 ), preferentially in dorsal horns, and corticospinal tracts 14 days after injury (Fig. 9) . A subset of MOG positive fibers also co-expressed GAP-43 ( Fig. 8D-I ).
Finally, immunoflorescence experiments conducted using GFAP as marker for astrocytes along with neuritin, attractin, and Mtap1a did not show expression of these proteins in astrocytes (data not shown).
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Neuritin, attractin, and Mtap1a temporal profile in DRG cells
Neuritogenesis of developing neurites share similar properties with regenerating axons. Both regenerating axons after injury and developing neurites extend their processes undergoing cytoskeleton remodeling at the growth cone, sharing expression of several proteins, including GAP-43 (25) (26) (27) (28) (29) . Therefore, E14 DRG cells were cultured in differentiation medium and baseline mRNA levels for neuritin, attractin, and Mtap1a were measured after 1 wk in culture by real time PCR.
The following time points were studied: 2, 3, and 5 wk. The three transcripts were significantly induced at all these time points. Both neuritin and attractin mRNA expression peaked at 2 wk and then progressively decreased, while Mtap1a showed a sustained expression level up to 5 weeks (Fig. 10) .
Overexpression of neuritin, membrane attractin, and MAP1a-LC2 promotes neurite outgrowth in DRG neurons
Neuritin, membrane attractin, and MAP1A-LC2 were transfected into E14 DRG neurons to evaluate their effect on neurite outgrowth. Positive cells were detected by eGFP (Fig. 11) , and only cells immunostained with both β-III tubulin, a neuronal marker, and GAP-43 were analyzed (not shown) 72 h post-transfection.
Over-expression of neuritin cDNA in DRG neurons resulted in a 42% increase in neurite length (Fig. 11) , as compared with transfection of attractin or MAP1A-LC2 alone, which did not induce increased neurite outgrowth vs. control (Fig. 11) . Nevertheless, combined transfection of attractin and MAP1A-LC2 had a synergistic effect that resulted in significant neurite extension (30% increase). Cotransfection experiments including combination of neuritin with MAP1A-LC2 (70% increase), and of neuritin with attractin (51% increase), resulted in increased neurite elongation compared with neuritin alone. Finally, when all three genes were overexpressed at the same time, the highest increment in neurite length was observed (94%), suggesting further synergy of these proteins in promoting neurite outgrowth.
DISCUSSION
After experimentally induced trauma to the rat spinal cord, we have identified a cluster of genes/proteins implicated in neuronal plasticity that show reduced expression at 24 h followed by coordinated recovery at 7-14 days after injury. The latter time period correlates with recovery of motor function. This cluster was identified using the expression profile of neuritin as the reference member and includes attractin, MOG, and Mtap1a. All of these proteins have been investigated with regard to neuronal and axonal development, differentiation, and function, but our report is the first to show the coordinated expression of these proteins in postmitotic neurons, which may reflect their role in axonal remodeling and plasticity. In addition, we demonstrate that coordinated expression of neuritin, membrane attractin, and MAP1A-LC2 is synergistic in promoting neurite outgrowth in DRG cells.
Neuritin, which is highly conserved across species, is expressed at peak levels during development, at times of axonal growth, dendritic growth, and synaptogenesis (34) (35) (36) . It is a GPI-linked membrane protein localized to nonmyelinated regions, which has an important role in modulating plasticity and neurite outgrowth (37, 38) . Although its function in postmitotic neurons of the DRG or spinal cord has not been a focus of study, neuritin also has a putative role in establishment of motor circuits, based on the detection of its message and protein in the spinal cord by developmental stage 47 (39) . Due to its clear association with neuritogenesis and its biphasic expression pattern after spinal cord trauma, we selected neuritin as the target gene member to search for other gene products with similar expression profiles. This led to identification of attractin, MOG, and Mtap1a as other members of the group with the inference that they too may function in the regenerative phase after injury.
At the conceptual level, the premise that grouping of these cluster members by expression profiling may represent a functional association appears to be supported. Attractin, a product of the ATRN/Atrn gene, is mutated in several animal models of postdevelopmental CNS hypomyelination with juvenile-onset neurodegeneration, including the Mahogany mouse, the zitter and myelin vacuolation rats, and the black tremor hamster (32, 40, 41) . Attractin has been shown to be involved in the regulation of neurite extension, pigmentation, and immune cell interactions; its pleiotropic functions seem to reflect an ability to influence the activity of positively-charged peptides including agouti and chemokines. Attractin mRNA is expressed throughout the CNS in neurons, with high expression found in ventral horns, intermediolateral nuclei, and dorsal horns in spinal cord (42) . Attractin knockout mice develop tremor at 3 wk of age and flaccid paresis of the hindlimbs at 6 months (40). The main pathological findings are progressive hypomyelination and vacuolation in CNS including spinal cord gray matter, pons, and cerebellum. The phenotype appears to be the result of defects in axonal-glial interaction, thereby impairing myelin assembly and formation. Experimental evidence suggests that membrane attractin may play a role in neurite formation in human cortical cells in vitro, probably by interacting with microtubules, and promoting their stabilization (43) .
The putative interaction of attractin with the microtubular network leads to examination of the role of MAP1A/Mtap1a. This protein is not believed to function during patterning of the nervous system where Map1b appears to have the dominant role, although there is one report (44) (45) (46) suggesting a role in late embryonic spinal cord fiber formation. Rather, Mtap1a functionality is believed to be expressed in brain regions where neurite growth persists in the adult and is expressed robustly during CNS myelination (46) , precisely the same developmental period that leads to neuropathology in mutant attractin animals. Mtap1a plays a key role in microtubule stabilization and maintenance. It has been suggested that MAP1a renders neuronal microtubules stable enough to support process outgrowth but still moderately dynamic so growing neurites remain plastic (43) . Taken together, these data support a role for Mtap1a in neuritogenesis and axonal plasticity.
MOG also enhances neurite outgrowth in embryonic spinal cord neurons cocultured with CHO cells (48) and supports axonal myelination. MOG expression is associated with myelin deposition (13, 49) and, unlike other myelin proteins, is specifically present in myelinated axons. This property enabled us to use MOG as a marker of new myelination after injury. More recently, MOG immunoreactivity has been described in NG2 positive oligodendrocytes precursors, implying a role of MOG in oligodendrocyte differentiation from precursor cells (50) .
GAP-43 has long been acknowledged to play a pivotal role in axonal plasticity and is used as a marker of regenerating neurite outgrowth and synaptogenesis, both in embryonic development and in neuronal process regeneration in injured brain and spinal cord (19, 28, (51) (52) (53) . It has been reported to promote axonal regeneration after spinal cord contusion injury (19) , although it is unlikely that GAP-43 is functioning at the structural level since cells deficient in GAP-43 display no problems in neurite extension. Rather, GAP-43 seems to play a crucial role in the path that the developing neurite will follow (54) . Consequently, the immunocytochemical colocalization of GAP-43 with neuritin, attractin, and MOG all support the proposal based on microarray expression data that these proteins may function together in helping extend the developing neurite during axonal regeneration.
A role in axonal plasticity and neurite outgrowth
We have shown that a group of genes that have been shown previously to play a role in central nervous system development (neuritin, attractin, Mtap1a, and MOG) are coordinately regulated following spinal cord trauma. Both mRNAs and proteins were down-regulated at 24 h postinjury in neurons and axons specifically in the injured group as opposed to shams. In a previous report, we showed a subset of damaged neurons expressing cell cycle proteins at 24 h undergo apoptotic cell death (30) . Taken together, our data suggest that SCI causes a rapid decline in the expression of genes involved in neuritogenesis, temporally associated with the expression of genes associated with cell death. Subsequent re-induction of the neuritogenesis cluster occurs in surviving neurons. We have verified this transcriptional repression at the protein level, and demonstrated that neuritin, Mtap1a and attractin genes/proteins were preferentially expressed in spinal cord neurons and axons that undergo axonal plasticity as shown by GAP-43 colocalization in both ventral and dorsal horns 14 days after injury. We also demonstrated that neuritin and GAP-43 were maintained in MOG positive axons, supporting a role of plasticity and neuritogenesis even in those fibers showing persistent myelination. Interestingly, attractin is also re-expressed 14 days after injury in dorsal cortico-spinal tracts positively stained with GAP-43, suggesting ongoing plasticity and proregeneration processes that have been associated with functional recovery (53) .
In vitro mRNA expression profiling showed that neuritin, attractin, and Mtap1a are expressed in DRG neurons cultured in differentiation medium. Significantly increased transcription was observed between 1 and 2 wk. However, only Mtap1a showed a sustained mRNA expression level until 5 wk, suggesting its potential role in prolonged cytoskeleton remodeling and stabilization necessary for neurite elongation.
The positive effect on neurite outgrowth in DRG neurons by overexpression of neuritin cDNA (42% increase in neurite length) suggests that neuritin plays an important role in neuritogenesis. Interestingly, no effect upon neurite outgrowth was seen when attractin or MAP1A-LC2 were overexpressed in DRGs, but combined overexpression of the two resulted in increased neurite elongation, suggesting a synergy between them. Although the LC2 chain is free to associate with MAP1B/Map1b as well as MAP1A/Mtap1a, 44 it is a post-translational cleavage product from the MAP1A mRNA. Accordingly, any change in expression and translation of Mtap1a will result in a coordinated change in expression of the LC2, and physical proximity after cleavage will likely lead to preferential association with the main Mtap1a chain. Importantly, using the yeast two-hybrid technique and expressed recombinant protein association, it has been observed that the cytoplasmic tail of attractin (completely conserved across all mammalian species) interacts with the LC2 of human MAP1A (W. Tang, J. H. Kim, and J. S. Duke-Cohan; personal communication). Therefore, we now suggest that this protein-protein interaction has a functional correlate in increased neurite outgrowth. In fact, neurite elongation mechanisms depend largely on protein-protein interaction between cytoplasmic and membrane protein domains, including the interaction at the cortical cytoskeleton between actin filaments and known cytoplasmic proregeneration proteins such as GAP-43 (56).
Such synergistic effects on neurite outgrowth were also observed by overexpressing neuritin with either attractin (51% increase) or MAP1A-LC2 (70% increase). A further additional effect on neurite elongation was achieved by overexpressing the three proteins together (94% increase), suggesting that temporal coregulation and co-expression of these proteins results in a coordinated biological function, and the coordinated expression of the cluster members may represent regulation of a regeneration-associated functional complex.
We speculate that these genes may act at the single cell level in a coordinated and sequential manner: neuritin triggering initial neurite development as well as axonal, dendritic, and synaptic plasticity; attractin helping to track developing processes and possibly to interact with Mtap1a (43), thus enhancing cytoskeleton re-arrangements appropriate for neurite extension, while MOG may play a major role in myelination. We believe that the systematic and co-ordinated use of microarray analysis with subsequent confirmation of protein behavior provides a reproducible and reliable methodology for identifying potential targets for therapeutic intervention aimed at enhancing regeneration. Accordingly, the cluster identified here of neuritin, attractin, MOG, and Mtap1a may form a functional complex for initial investigation. Shown is a gene tree showing neuritin cluster obtained using neuritin as anchor gene (red box) to nucleate transcripts with a similar profile across time point (R2: 0.98). All genes show significant downregulation after injury compared with shams at 24 h time point (*P<0.05, Welch t test). mRNA expression levels recover to normal levels by 14 days after injury. Gene expression levels in both sham and injured groups were normalized to time point 0 (naïve animals). Bar graph on right is color code for gene expression level (red: high; blue: low). 
